Stay updated on TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.

Latest updates to the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page
- Check4 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, stock, or time-slot availability.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in South Korea, Russia, and Poland, as well as updates to related medical topics such as Alzheimer's disease and drug safety. Notably, the previous version's references to certain locations and topics have been removed.SummaryDifference27%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild-Moderate Alzheimer's Disease Clinical Trial page.